The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
Name:
37263081.pdf
Size:
442.2Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Ducreux, M.Abou-Alfa, G. K.
Bekaii-Saab, T.
Berlin, J.
Cervantes, A.
de Baere, T.
Eng, C.
Galle, P.
Gill, S.
Gruenberger, T.
Haustermans, K.
Lamarca, Angela
Laurent-Puig, P.
Llovet, J. M.
Lordick, F.
Macarulla, T.
Mukherji, D.
Muro, K.
Obermannova, R.
O'Connor, J. M.
O'Reilly, E. M.
Osterlund, P.
Philip, P.
Prager, G.
Ruiz-Garcia, E.
Sangro, B.
Seufferlein, T.
Tabernero, J.
Verslype, C.
Wasan, H.
Van Cutsem, E.
Affiliation
Université Paris-Saclay, Gustave Roussy, Villejuif, France.Issue Date
2023
Metadata
Show full item recordAbstract
This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.Citation
Ducreux M, Abou-Alfa GK, Bekaii-Saab T, Berlin J, Cervantes A, de Baere T, et al. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022. ESMO open. 2023 May 30;8(3):101567. PubMed PMID: 37263081. Pubmed Central PMCID: PMC10245111. Epub 2023/06/02. eng.Journal
ESMO OpenDOI
10.1016/j.esmoop.2023.101567PubMed ID
37263081Additional Links
https://dx.doi.org/10.1016/j.esmoop.2023.101567Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.esmoop.2023.101567
Scopus Count
Collections
Related articles
- The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008.
- Authors: Verslype C, Van Cutsem E, Dicato M, Arber N, Berlin JD, Cunningham D, De Gramont A, Diaz-Rubio E, Ducreux M, Gruenberger T, Haller D, Haustermans K, Hoff P, Kerr D, Labianca R, Moore M, Nordlinger B, Ohtsu A, Rougier P, Scheithauer W, Schmoll HJ, Sobrero A, Tabernero J, van de Velde C
- Issue date: 2009 Jun
- Management of hepatocellular carcinoma: SASL expert opinion statement.
- Authors: Goossens N, Toso C, Heim MH
- Issue date: 2020 Jul 27
- Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
- Authors: Abdel-Rahman O, Elsayed Z
- Issue date: 2020 Jan 24
- From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
- Authors: Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D, Sakellariou S, Kykalos S, Tsourouflis G, Garmpi A, Delladetsima I, Kontzoglou K, Kouraklis G
- Issue date: 2017 Aug 7
- Hepatocellular carcinoma from the view of gastroenterologist/hepatologist.
- Authors: Petr U, Petr H
- Issue date: 2020 Fall